Q-omics provides the consensus-scored WASF4P profile across patient tissues and cancer cell-line models. WASF4P expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, WASF4P is differentially expressed in 6, with the highest sampling consensus in THCA. Additionally, WASF4P RNA expression shows 16,505 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight HNSC, THCA, and THYM as cancer lineages where WASF4P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for WASF4P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes WASF4P survival associations across molecular data types. WASF4P RNA expression shows survival associations in the most cancer types (22), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible WASF4P RNA expression–survival associations across cancer types. High WASF4P expression shows unfavorable associations in OV, LIHC and LGG, but favorable associations in HNSC, KIRC and BRCA. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for WASF4P RNA expression.
This table summarizes WASF4P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for WASF4P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. WASF4P shows lower tumor expression in THCA and STAD and higher tumor expression in COAD, HNSC, LUSC and KIRC. The THCA box plot shows higher WASF4P RNA expression in normal versus tumor tissue (log2 FC = −0.092, t-test p < 0.001).
This table shows molecular features associated with WASF4P in patient tissues and cancer cell lines. In patient samples, WASF4P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
